Vical inks $4M contract to manufacture HIV vaccine; Buffalo, NY, cancer institute to develop lung cancer vax with Cuban partner;

> San Diego-based Vical ($VICL) signed a $4 million contract with the IPPOX Foundation to supply plasmid DNA for HIV vaccine clinical trials. It is funded by a grant from the Bill & Melinda Gates Foundation. Release

> The Roswell Park Cancer Institute in Buffalo, New York, signed an agreement with Cuba's Center for Molecular Immunology to develop a lung cancer vaccine. News

> A large study published by JAMA shows no link between the MMR vaccine and autism. More (sub. req.)

> Researchers in Singapore and China have developed nanoparticle-coated bacteria that can potentially be used to deliver DNA cancer vaccines. FierceDrugDelivery story | More

And Finally… U.S. Surgeon General Vivek Murthy explains vaccination to Elmo in a video produced by The Daily Dot. Video

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.